Illumina (ILMN) Stock Highlights

94.2 | -3.09%

2025-02-22 01:01:43

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illuminas high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Statistics

Range Today

93.5 98.7

Volume Today 4.22M

Range 1 Year

95.23 156.66

Volume 1 Year 535.53M

Range 3 Year

86.58 361.05

Volume 3 Year 1.35B

Range 10 Year

86.58 540.63

Volume 10 Year 3.43B

Highlights

Market Capitalization 14.92B (large)

Floating Shares 157.93M

Current Price 94.2

Price To Earnings -12.74

Price To Revenue 3.84

Price To Book 6.31

Earnings Per Share -7.69

Payout Ratio 0%

Performance

Latest -3.09%

1 Month -31.72%

3 Months -28.28%

6 Months -28.93%

1 Year -29.57%

3 Years -68.86%

5 Years -67.72%

10 Years -52.4%

Benchmarks

Market Capitalization

9 / 58

Gross Profits

7 / 52

Total Revenue

9 / 57

Total Rank

7 / 58

Free Cashflow

12 / 56

Performance 5 years

39 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.